MedPath

山西千汇药业有限公司

Ownership
-
Established
1996-03-19
Employees
-
Market Cap
-
Website
http://www.qhyy.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

40

NMPA:40

Drug Approvals

Macrogol 4000 Powder

Product Name
聚乙二醇4000散
Approval Number
国药准字H20253498
Approval Date
Mar 4, 2025
NMPA

Azithromycin Granules

Product Name
阿奇霉素颗粒
Approval Number
国药准字H20093277
Approval Date
Dec 28, 2023
NMPA

银黄含化滴丸

Approval Number
国药准字Z20080475
Approval Date
May 22, 2023
NMPA

Chlorzoxazone Tablets

Product Name
氯唑沙宗片
Approval Number
国药准字H14023710
Approval Date
Jan 28, 2022
NMPA

姆益牌芦荟花粉茯苓胶囊

Approval Number
国食健注G20070210
Approval Date
Apr 22, 2021
NMPA

Vitamin U,Belladonna and Aluminium Capsules(Ⅲ)

Product Name
维U颠茄铝胶囊(Ⅲ)
Approval Number
国药准字H14022934
Approval Date
Jan 27, 2021
NMPA

Compound Paracetamol and Amantadine Hydrochloride capsules

Product Name
复方氨酚烷胺胶囊
Approval Number
国药准字H22025791
Approval Date
Sep 21, 2020
NMPA

Alginic Sodium Diester Tablets

Product Name
藻酸双酯钠片
Approval Number
国药准字H14022901
Approval Date
Aug 6, 2020
NMPA

Saccharated Pepsin

Product Name
含糖胃蛋白酶
Approval Number
国药准字H14022179
Approval Date
Aug 6, 2020
NMPA

Cefalexin Capsules

Product Name
头孢氨苄胶囊
Approval Number
国药准字H14020874
Approval Date
Aug 6, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.